Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.5.5 (
CPS
)
1,262
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver development is regulated by soluble factors as well as cell-cell contacts. We previously reported that
oncostatin M
(
OSM
) induced hepatic maturation in a primary culture of embryonic day 14 liver cells. While
OSM
expression in the liver starts in mid gestation and decreases in postnatal stages, hepatocyte growth factor (HGF) is mainly expressed in the liver in the first few days after birth. In this study, we compared the effect of
OSM
and HGF on the differentiation of fetal hepatic cells in vitro. Like
OSM
, HGF in the presence of dexamethasone induced expression of glucose-6-phosphatase, tyrosine amino transferase and
carbamoyl-phosphate synthase
, and accumulation of glycogen in fetal hepatic cells, although to a lesser extent than
OSM
. Interestingly, while both
OSM
and HGF up-regulated production of albumin, secretion of albumin occurred only in response to
OSM
. In addition, although hepatic maturation induced by
OSM
depends on STAT3, HGF failed to activate STAT3 and HGF-induced differentiation was independent of STAT3. These results indicate that
OSM
and HGF induce hepatic maturation through different signaling pathways.
...
PMID:Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. 1124 43